145 related articles for article (PubMed ID: 13364205)
21. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
[TBL] [Abstract][Full Text] [Related]
22. Drug-induced release and pharmacodynamic effects of histamine in the guinea-pig heart.
Pöch G; Kukovetz WR
J Pharmacol Exp Ther; 1967 Jun; 156(3):522-7. PubMed ID: 4165875
[No Abstract] [Full Text] [Related]
23. Is endogenous histamine involved in the contraction of the isolated trachea, evoked by muscarinic agonist?
Korosec L; Stanovnik L
Inflamm Res; 1999 Apr; 48 Suppl 1():S37-8. PubMed ID: 10350152
[No Abstract] [Full Text] [Related]
24. Action of histamine liberator compound 48/80 in the guinea pig; with a review of previous reports of its action in other species.
FEINBERG SM; STERNBERGER LA
J Allergy; 1955 Mar; 26(2):170-9. PubMed ID: 14353606
[No Abstract] [Full Text] [Related]
25. Distinct effects of antigen and compound 48/80 in the guinea pig trachea.
Liu J; Kolmert J; Säfholm J; Johnsson AK; Zurita J; Wheelock CE; Dahlén SE; Nilsson G; Adner M
Allergy; 2021 Jul; 76(7):2270-2273. PubMed ID: 33619732
[No Abstract] [Full Text] [Related]
26. Histamine in the skin of mice with hereditary muscular dystrophy.
O'Steen WK; Hrachovy JJ
Tex Rep Biol Med; 1965; 23(4):762-6. PubMed ID: 5886406
[No Abstract] [Full Text] [Related]
27. Bronchodilatory and mast cell stabilising activity of Cressa cretica L.: evaluation through in vivo and in vitro experimental models.
Priyashree S; Jha S; Pattanayak SP
Asian Pac J Trop Med; 2012 Mar; 5(3):180-6. PubMed ID: 22305781
[TBL] [Abstract][Full Text] [Related]
28. ACTION OF VARIOUS DRUGS ON THE TISSUE HISTAMINE AND 5-HYDROXYTRYPTAMINE CONTENTS OF COMMON LABORATORY ANIMALS.
BHATT KG; JALOTA R; SANYAL RK
Indian J Med Res; 1964 Jan; 52():52-62. PubMed ID: 14112163
[No Abstract] [Full Text] [Related]
29. [Heterogeneity and specificity of mastocyte populations].
Lecomte J; Damas J
Bull Mem Acad R Med Belg; 1986; 141(7):399-406. PubMed ID: 2434170
[No Abstract] [Full Text] [Related]
30. Mast cell disruption and other changes in the pericorneal tissue morphology after intraperitoneal injections of a potent histamine liberator (compound 48/80).
Garden JW
Invest Ophthalmol; 1965 Oct; 4(5):835-43. PubMed ID: 5831991
[No Abstract] [Full Text] [Related]
31. Effect of compound 48/80 on mast cells and histamine levels in rat brain and on corticosterone secretion.
Bugajski AJ; Chłap Z; Gadek-Michalska A; Borycz J; Bugajski J
Inflamm Res; 1997 Mar; 46 Suppl 1():S47-8. PubMed ID: 9098759
[No Abstract] [Full Text] [Related]
32. Quantitative correlation between degranulation and histamine release following exposure of rat mast cells to compound 48-80 in vitro.
Nosal R; Slorach SA; Uvnäs B
Acta Physiol Scand; 1970 Jun; 79(2):31A-32A. PubMed ID: 5454905
[No Abstract] [Full Text] [Related]
33. [On the significance of phospholipase A for the histamine-liberating action of cobra venom].
May B; Holler C; Westermann E
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 256(2):237-56. PubMed ID: 4174223
[No Abstract] [Full Text] [Related]
34. The inhibitory action of adenosine-5'-triphosphate (ATP) on histamine release and mast cell degranulation induced by compound 48-80.
Diamant B; Dahlquist R
Acta Pharmacol Toxicol (Copenh); 1970; 28(1):44. PubMed ID: 4103484
[No Abstract] [Full Text] [Related]
35. [Study of fish-scale labrocytes: effect of a histamine liberator (compound 48-80) and seasonal variations].
VEIL C
J Physiol (Paris); 1956; 48(3):736-41. PubMed ID: 13346619
[No Abstract] [Full Text] [Related]
36. Histamine releasing properties of the anthelmintic, 1-diethylcarbamyl-4-methylpiperazine citrate, (diethylcarbamazine).
Deline TR; Eyre P; Wells PW
Arch Int Pharmacodyn Ther; 1973 Sep; 205(1):192-8. PubMed ID: 4127976
[No Abstract] [Full Text] [Related]
37. Evidence for energy-requiring processes in histamine release and mast cell degranulation in rat tissues induced by compound 48/80.
DIAMANT B; UVNAS B
Acta Physiol Scand; 1961; 53():315-29. PubMed ID: 13886091
[No Abstract] [Full Text] [Related]
38. Quantitative determination of mast cell fragmentation by compound 48/80.
NORTON S
Br J Pharmacol Chemother; 1954 Dec; 9(4):494-7. PubMed ID: 13219275
[No Abstract] [Full Text] [Related]
39. Quantitative correlation between degranulation and histamine release following exposure of rat mast cells to compound 48-80 in vitro.
Nósal R; Slorach SA; Uvnäs B
Acta Physiol Scand; 1970 Oct; 80(2):215-21. PubMed ID: 4097580
[No Abstract] [Full Text] [Related]
40. Inhibitory effect of MY-1250 on histamine release from rat peritoneal mast cells and guinea pig lung fragments: the elucidation of the mechanism.
Kamei C; Mio M; Izushi K; Yoshii N; Fujisawa K; Tasaka K
Immunopharmacol Immunotoxicol; 1991; 13(3):341-56. PubMed ID: 1719061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
